MultiPlan Rebrands as Claritev, Shifts Focus to Data and Tech Solutions

MultiPlan, a longstanding player in the healthcare data analytics space, has unveiled a significant rebrand and strategic shift at the ViVE 2025 digital health conference. The company, now known as Claritev, aims to position itself as a leading health tech provider offering data-driven solutions to a broader range of healthcare stakeholders.
Rebranding and Strategic Realignment
Claritev's rebrand reflects its evolving focus on developing new products and technologies that provide actionable data insights across the healthcare market. Travis Dalton, chairman, CEO, and president of Claritev, emphasized the company's desire to be recognized as a health tech innovator, stating, "I want us to be seen more as the health tech company we are."
The company will begin trading under the new ticker symbol CTEV on the New York Stock Exchange starting February 28, marking a new chapter in its 45-year history.
Expanding Service Offerings and Partnerships
Claritev is broadening its scope beyond its traditional role in cost management services and out-of-network medical bill analytics. The company now offers a range of data science tools and price transparency platforms, including:
-
CompleteVue: A software solution launched in December that leverages publicly available price transparency data to provide advanced analytics for health systems and providers.
-
BenInsights: A platform built on technology acquired from Benefits Science Technologies, optimizing financial and clinical decision-making for approximately 75,000 employers.
Additionally, Claritev has formed strategic alliances to expand its reach, including a partnership with the National Rural Health Association to increase rural healthcare providers' access to data science and tech-enabled solutions.
Technological Advancements and Infrastructure Investments
Claritev has made significant strides in upgrading its technological capabilities. In January, the company announced a substantial partnership with Oracle, involving a "nine-figure investment" to consolidate its cloud infrastructure on Oracle Cloud Infrastructure (OCI). This move is expected to enhance Claritev's ability to develop new solutions and serve a wider array of healthcare organizations.
Dalton envisions creating publicly available APIs based on a data platform that utilizes public data, which could benefit value-based care companies and managed care organizations working to capitate risk.
Industry Challenges and Legal Scrutiny
Despite its rebranding efforts and strategic pivot, Claritev faces ongoing challenges in the form of public scrutiny and legal action. The company is currently embroiled in multidistrict litigation consolidating dozens of plaintiff complaints, including cases filed by individual health systems and the American Medical Association. These lawsuits allege anticompetitive practices in Claritev's agreements with major insurers to set out-of-network prices.
Dalton maintains that the lawsuits are "absolutely without merit" and argues that successful litigation against the company could lead to increased prices for patients and employers. However, the legal challenges underscore the complex and often contentious role Claritev plays in the healthcare ecosystem.
As Claritev navigates these challenges and pursues its new strategic direction, the company's evolution will likely have significant implications for the broader healthcare technology and data analytics landscape.
References
- ViVE 2025: MultiPlan unveils rebrand as it shifts focus to data assets, tech for providers, payers and employers
As both regulatory and market forces are pushing the industry toward more transparency in healthcare pricing, MultiPlan sees opportunities to be a bigger player in data and tech for providers, payers and employers.
Explore Further
What is the financial impact of Claritev's rebranding and strategic shift on its market performance?
How does Claritev's nine-figure investment in Oracle Cloud Infrastructure enhance its service capabilities?
What is the current state of the lawsuits involving Claritev, and how might they affect the company's future strategy?
What are the competitive advantages of Claritev's new data science tools like CompleteVue and BenInsights?
How do Claritev's strategic partnerships, such as with the National Rural Health Association, expand its market reach?